Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gammopathy”

154 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 154 results

Very early researchWithdrawnNCT03591614
What this trial is testing

Dendritic Cell DKK1 Vaccine for Monoclonal Gammopathy and Stable or Smoldering Myeloma

Who this might be right for
Monoclonal GammopathySmoldering MyelomaMyeloma
Case Comprehensive Cancer Center
Not applicableEnrolling By InvitationNCT07661667
What this trial is testing

This Study Aims to Investigate the Efficacy of Photobiomodulation in the Treatment of Anti-MAG-induced Peripheral Neuropathy (LASER-MAG)

Who this might be right for
Anti MAG Neuropathy
Centre Hospitalier de Cornouaille 10
Not applicableStudy completedNCT03951220
What this trial is testing

The Development and Pilot Testing of a New MR Imaging Protocol to Quantify Myeloma Disease Burden and Bone Loss

Who this might be right for
MyelomaMonoclonal Gammopathy of Undetermined Significance (MGUS)Smouldering Myeloma
Oxford University Hospitals NHS Trust 67
Not applicableLooking for participantsNCT07214324
What this trial is testing

Integrative Multi-omics Analysis to Predict Monoclonal Gammopathies Clinical Evolution

Who this might be right for
Monoclonal Gammopathy of Undetermined Significance (MGUS)Smoldering Multiple Myeloma (SMM)Multiple Myeloma (MM)
Azienda USL Reggio Emilia - IRCCS 60
Not applicableStudy completedNCT00919139
What this trial is testing

S0309, Repository: Blood/Bone Marrow From Pts. With Myeloma, WM, Amyloidosis, or MGUS.

Who this might be right for
Multiple MyelomaSmoldering MyelomaWaldenstrom's Macroglobulinemia+2 more
SWOG Cancer Research Network 190
Testing effectiveness (Phase 2)Looking for participantsNCT07209371
What this trial is testing

Rifaximin Versus No Intervention for the Treatment of IgG/IgA (Non-IgM) Monoclonal Gammopathy of Undetermined Significance

Who this might be right for
IgA Monoclonal Gammopathy of Undetermined SignificanceNon-IgM Monoclonal Gammopathy of Undetermined Significance
Fred Hutchinson Cancer Center 50
Testing effectiveness (Phase 2)Ended earlyNCT01548573
What this trial is testing

Tandem Auto Transplantation in Myeloma Patients With <12 Months of Prior Treatment

Who this might be right for
Multiple Myeloma
University of Iowa 19
Testing effectiveness (Phase 2)Looking for participantsNCT06083922
What this trial is testing

CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)

Who this might be right for
Multiple MyelomaMonoclonal Gammopathy of Renal Significance
Memorial Sloan Kettering Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT00006379
What this trial is testing

Non-Ablative Allo HSCT For Hematologic Malignancies or SAA

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+5 more
Case Comprehensive Cancer Center 58
Not applicableUnknownNCT04727294
What this trial is testing

MGUS, SMM, and MM Patient Experience With Coronavirus 19 (COVID-19) Survey

Who this might be right for
Multiple MyelomaSmoldering Multiple MyelomaMonoclonal Gammopathy of Undetermined Significance+1 more
HealthTree Foundation 1,500
Not applicableStudy completedNCT04615572
What this trial is testing

Screening to Improve Survival in AL Amyloidosis

Who this might be right for
Smoldering Multiple MyelomaMonoclonal Gammopathy of Undetermined Significance
Tufts Medical Center 35
Not applicableLooking for participantsNCT07446777
What this trial is testing

FAST-M: Prolonged Overnight Fasting and Mediterranean Dietary Intervention for Patients With Multiple Myeloma or Its Precursor Disease

Who this might be right for
Multiple MyelomaMonoclonal Gammopathy of Undetermined SignificanceSmoldering Multiple Myeloma
University of Miami 120
Not applicableEnded earlyNCT00726830
What this trial is testing

Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
M.D. Anderson Cancer Center 1
Early research (Phase 1)Study completedNCT00003451
What this trial is testing

Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Looking for participantsNCT06140524
What this trial is testing

A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma

Who this might be right for
Monoclonal Gammopathy of Undetermined Significance (MGUS)Smoldering Multiple Myeloma (SMM)
Regeneron Pharmaceuticals 116
Testing effectiveness (Phase 2)Looking for participantsNCT05573802
What this trial is testing

Investigate Safety and Clinical Activity of Belantamab Mafodotin in Combination With Lenalidomide, Dexamethasone and Nirogacestat in Patients With Transplant Ineligible Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple MyelomaNeoplasmsNeoplasm, Plasma Cell+5 more
Hellenic Society of Hematology 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT03236428
What this trial is testing

Phase II Study of the CD38 Antibody Daratumumab in Patients With High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma

Who this might be right for
Monoclonal GammopathySmoldering Multiple Myeloma
Dana-Farber Cancer Institute 42
Testing effectiveness (Phase 2)Study completedNCT00132015
What this trial is testing

17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic Mastocytosis

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
National Institutes of Health Clinical Center (CC) 37
Not applicableUnknownNCT06489613
What this trial is testing

Screening for Monoclonal Gammopathy in Individuals Undergoing Physical Examinations Using iMS-LC Assay Technology.

Who this might be right for
M ProteinMonoclonal GammopathyMonoclonal Gammopathy of Undetermined Significance
Jian Li 15,600
Not applicableStudy completedNCT06559579
What this trial is testing

Monoclonal Gammopathy With Clinical Significance in Patients With and Without Haematological Malignancies in Finistère Between 2012 and 2017 (GammaClinik)

Who this might be right for
Gammopathy, Monoclonal
University Hospital, Brest 80
Next Page